European Archives - Page 136 of 1097 - European Medical Journal

Adult-Onset Egg White Allergy: Quality of Life Effects

In a small Swiss study, patients with adult-onset egg white allergy exhibited moderate to severe restrictions in daily life.

Clinical Trial Validates New MASLD Drug Therapy

This study examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.

Ed Smith

Onc Now: Episode 6: Revolutionising Paediatric Radiation Oncology – Part 1

Join Ed Smith, Professor at the University of Manchester, UK, to discuss the revolutionary potential of proton beam therapy and radiation oncology.

3D-Printed Hydrogel Contact Lens to Transform Ocular Drug Delivery

Discover the future of eye care: 3D-printed contact lenses delivering medication directly and effectively using innovative hydrogels.

Mobile Apps Helpful in Rheumatoid Arthritis Self-Care and Symptom Management

Discover how a mobile app empowers rheumatoid arthritis patients to self-manage symptoms, providing valuable insights without increasing psychological burden.

The word spotlight on a blue background

Spotlight: November 2024

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.

Chronic Endometritis Worsens Pregnancy Risks for Women with Endometriosis

Patients with endometriosis and chronic endometritis face higher pregnancy risks despite improved fertility, highlighting the need for careful management.

Lung Cancer Screening Benefits Limited for Smokers with Severe Airflow Limitation

The study followed 18,463 high-risk smokers, who underwent pre-bronchodilator spirometry tests and were tracked over a median period of 6.1 years.

ABPI calls for MHRA reform to drive UK life sciences growth

As the MHRA begins a new chapter, the ABPI has published a report outlining the importance of regulatory excellence in the UK.

Parkinson’s Disease Drug Disrupts the Gut Microbiome

An international study has uncovered significant effects of two widely used neurological drugs, entacapone and loxapine succinate, on gut microbial communities.